Back
Imperial Brands PLC Vs. Monopar Therapeutics Industry Stock Comparison
Sell
44
IMBBY
Imperial Brands PLC
Last Price:
$32.37
Seasonality Move:
-1.29%
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$39.20
Seasonality Move:
-13.19%
Sell
44
Imperial Brands PLC (IMBBY)
is a Sell
Is Imperial Brands PLC a Buy, Sell or Hold?
-
The current Imperial Brands PLC [IMBBY] share price is $32.04. The Score for IMBBY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
IMBBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $33.67. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IMBBY Stock Price Chart
What is Imperial Brands PLC's stock price today?
-
The Imperial Brands PLC share price today is $32.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMBBY is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $33.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
IMBBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 50.12 | Buy |
| Chaikin Money Flow: | -21193 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.22 | Buy |
| Relative Strength Index (14 RSI): | 68.66 | Buy |
| Chaikin Money Flow: | 9701 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
IMBBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.76 | Buy |
| 20-day SMA: | 32.08 | Sell |
| 50-day SMA: | 31.99 | Buy |
| 200-day SMA: | 27.99 | Buy |
| 8-day EMA: | 31.93 | Buy |
| 20-day EMA: | 32.04 | Sell |
| 50-day EMA: | 31.71 | Buy |
| 200-day EMA: | 28.74 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.41 | Buy |
| 20-day SMA: | 25.66 | Buy |
| 50-day SMA: | 23.12 | Buy |
| 200-day SMA: | 9.21 | Buy |
| 8-day EMA: | 29.2 | Buy |
| 20-day EMA: | 26.65 | Buy |
| 50-day EMA: | 22.7 | Buy |
| 200-day EMA: | 12.39 | Buy |
Imperial Brands PLC Earnings Growth & IMBBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.20 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.41 per share.
Imperial Brands PLC Technical Analysis
| Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||